Delivery Order SPE2DB22D3501-SPE2DB24FWM43

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,816,295 units of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,823.85 and a period of performance through January 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $9,584.41 and runs through September 5, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg inhaler units. The contract has a firm fixed price of $1,764.05 and an ultimate completion date of August 21, 2024. It is not designated as a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers. The $3,227.09 firm fixed price contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,977.92, is for the delivery of fluticasone propionate HFA 110 MCG 12GM inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Propionate HFA 220 MCG 12GM inhalers. The contract is a firm fixed-price, delivery order type with a ceiling value of $2,919.84 and a performance period ending on July 25, 2024. This contract award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. The contract has a firm fixed price and a ceiling value of $9,338.45. There is no set-aside designation for this award. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Propionate HFA 220 mcg inhalers. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,013.12, is for the supply of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Propionate Inhalation Aerosol (110 mcg, 12 g). The contract has a firm-fixed price of $1,212.30 and an ultimate completion date of September 9, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWM43
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. The contract has a firm fixed price of $4,139.18 and a period of performance through August 2, 2024. As a general supply contract, this award does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for providing a wide range of pharmaceutical and medical products to support military treatment facilities and other federal healthcare programs. This specific delivery order is part of that overarching IDC, ensuring consistent access to critical respiratory medication for the U.S. military and other government beneficiaries.

Generated 10/31/24, 9:30 AM